Minneapolis, MN, United States of America

Emily Meyering

This inventor holds 1 USPTO granted patent. Top assignee: Moonshot Medical LLC. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emily Meyering: Innovator in Hemostatic Formulations

Introduction

Emily Meyering is a talented inventor based in Minneapolis, MN (US). She has made significant contributions to the field of medical innovations, particularly in the development of hemostatic foams. Her work focuses on creating formulations that enhance blood coagulation, which can be crucial in medical emergencies.

Latest Patents

Emily holds a patent for a hemostatic formulation that includes a gas component, a liquid vehicle, a surfactant, and at least one of a mucosoadhesive or a thickening agent. The formulation may utilize Carbopol as the thickening agent and incorporate coagulants such as chitosan, kaolin, or chitin. Additionally, the surfactant may consist of polysorbate and glycerol, while a viscosity-enhancing agent, such as poly-N-isopropylacrylamide (pNIPAM), may also be included. This innovative approach aims to improve the effectiveness of hemostatic agents in clinical settings.

Career Highlights

Emily is currently employed at Moonshot Medical LLC, where she continues to advance her research and development efforts. Her dedication to innovation in medical technology has positioned her as a key player in her field.

Collaborations

Emily collaborates with her coworker, Benjamin Arcand, to further enhance the impact of their work in hemostatic formulations.

Conclusion

Emily Meyering's contributions to the field of hemostatic formulations demonstrate her commitment to improving medical outcomes through innovation. Her patent and ongoing work at Moonshot Medical LLC highlight her role as a significant inventor in the medical technology landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…